A review on lung cancer
Abstract
Lung cancer is a kind of cancer that starts as a growth of cells in the lungs. The lungs are two spongy organs in the chest that control breathing. People who smoke have the greatest risk of lung cancer. The risk of lung cancer increases with the length of time and number of cigarettes smoked. Quitting smoking, even after smoking for many years, significantly lowers the chances of developing lung cancer. Lung cancer also can happen in people who have never smoked. Lung cancer is the prime cause of cancer death among both men and women according to WHO report 2.09 million cases globally. It is also the chief cause of cancer death among men and the second leading cause of cancer death among women worldwide. The lung cancer classified into two different types is small-cell lung cancers (SCLC) and non-small-cell lung cancers (NSCLC). This article focuses on modifiable risk factors, including tobacco smoking, occupational carcinogens, diet, and ionizing radiation. It also discusses briefly the molecular and genetic aspects of lung carcinogenesis. Lung cancer is the most frequent cancer type with high mortality and morbidity rate worldwide. Studies have chemotherapy. own that smoking, environmental factors including occupational exposure, radon exposure, air pollution, radiation, obesity, diet and hereditary susceptibility are related to developing risk of LC.
References
2.V. Sankar, R. Kothai. Lung cancer , International journal of health sciences and Research. Vol:13; Issue:10; October 2023.
3. Cagnur Elpen Kodaz. Lung Cancer Risk factors. Eurasian journal of medical advances. 2022;2(4):159–162.
4. V. Sankar, R. Kothai, N. Vanisri1, Akilandeswari. S1, G. Anandharaj. Lung Cancer. International Journal of Health Sciences and Research.2023; Vol.13; Issue: 10.
5. Faraz Siddiqui; Sarosh Vaqar; Abdul H. Siddiqui. Lung Cancer.2023.
6. Madhava Reddy P V, Guduru Rajeswari, Satrasala Neelima, & Arava Vidyadhari. Cancer Immunotherapy: Theory and it’s Application. , Future J. Pharm. Health. Sci, 2022, 2(4), 256–268.
7. Faraz Siddiqui; Sarosh Vaqar; Abdul H. Siddiqui. Lung Cancer.2023.
8. Cecilia Zappa, shaker A. Mousa. Non-small cell lung cancer: current treatment and future advances. Translational lung cancer research. Journal focusing on closing the gap between “bench and depside”, Vol:5, No:3 (June 30,2016).
9. Lynne Eldrige, MD how non-small cell lung cancer is treated . Updated on October 13, 2024 https://www.verywellhealth.com/cancer-overview-4581995.
10. Squamous Cell Carcinoma in the Lungs: What to Know By Lynne Eldridge, MD Updated on October 11, 2024 Medically reviewed by Doru Paul, MD
11. lung adenocarcinoma dogodan therapeutics, inc http://www.dogodon.com/home/luad
12. https://my.clevelandclinic.org/
13.Charles M. Rudin, Elisabeth Brambilla, Corinne Faivre-Finn & Julien Sage Small-cell lung cancer Nature Reviews Disease Primers volume 7, Article number: 3 (2021)
14. Charles S. Dela Cruz. Clin chest Med, Lung cancer; Epidemiology, Etiology and Prevention, National Library of Medicine; 3 November 2011.
15. Aishwarya Anand, Sowmya M, & Kamiel S. A Review on Drug-Drug Interactions Between Cancer Drugs. Int. J. of Clin. Pharm. Med. Sci, 2021, 1(3), 73–80.
16.https://indonesianrecipes.com/download/openpicture.php?img=https://i0.wp.com/post.healthline.com/wp-content/uploads/2021/12/1796042-MR-CLONE-Early-Signs-of-Lung-Cancer-1297x2788-body-1296x2375.png?w=1155&h=4995of small cell lung cancer
17. https://Searchapi.cancer.org.
18. Austin J. Sim , Evangelia Kaza , Lisa Singer , Stephen A. Rosenberg A review of the role of MRI in diagnosis and treatment of early-stage lung cancer vol 24, sep 2020, pages 16-22.
19. Stefan Hammerschmidt, Hubert Wirtz Lung Cancer: Current Diagnosis and Treatment 106(49): 809–20, 2009.
20. Lung cancer - Diagnosis and treatment - Mayo Clinic
21. Cecilia zappa, shaker A. Mousa. Non - small cell lung cancer: current treatment and future advances, translational lung cancer research. journal focusing on closing the gap between “bench and dedside”, vol:5, no:3 (June 30,2016).
22. Tepotinib: Uses, Interactions, Mechanism of Action | DrugBank Online.

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright © Author(s) retain the copyright of this article.
Most read articles by the same author(s)
- N. Hemalatha, M. Sowjanya, Y. Prapurna Chandra, Venugopalaiah Penabaka, Yerikala Ramesh, A review on leukemia: advances in diagnosis, treatment and prognosis , Journal of Innovations in Applied Pharmaceutical Science (JIAPS): Volume-10, Issue-1, 2025
- Bandi Nithin, Sarvepalli Revathi, Venugopalaiah Penabaka, Y Prapurna Chandra, Review on tanacetum parthenium , International Journal of Indigenous Herbs and Drugs: Volume-10, Issue-1, 2025
- U. Thrisharika, M. Sowjanya, Y Prapurna Chandra, Yerikala Ramesh, Venugopalaiah Penabaka, A review on urinary tract infection on pediatric and womens health , International Journal of Health Care and Biological Sciences: Volume-6, Issue-1, 2025
- Ravuri Venkata Suvarna, M. Sowjanya, Y Prapurna Chandra, Venugopalaiah Penabaka, Afroz Patan, A review on exploring link between maternal tsh levels during gestational hypothyroidism and foetal developmental mile stones , International Journal of Health Care and Biological Sciences: Volume-6, Issue-4, 2025
- Ravuru Jyothirlatha, M. Sowjanya, Y Prapurna Chandra, Venugopalaiah Penabaka, Afroz Patan, A review on consequences on foetal development during alcohol induced mother , Journal of Case Studies and Case Reports: Volume-4, Issue-2, 2025

.